메뉴 건너뛰기




Volumn 2, Issue 3, 2001, Pages 348-353

DAPD Emory University/Triangle Pharmaceuticals/Abbott Laboratories

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 3' AZIDO 2',3' DIDEOXY 5 METHYLCYTIDINE; ADENOSINE DEAMINASE; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; BETA D 2,6 DIAMINOPURINE DIOXOLANE; DIDANOSINE; DIOXOLANE GUANINE; DNA POLYMERASE; EMTRICITABINE; FAMCICLOVIR; LAMIVUDINE; NEVIRAPINE; PRODRUG; PROTEINASE INHIBITOR; PURINE NUCLEOSIDE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; UNCLASSIFIED DRUG; VIRUS DNA; ZALCITABINE; ZIDOVUDINE;

EID: 0035062365     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (16)

References (34)
  • 3
    • 0005343974 scopus 로고    scopus 로고
    • Triangle Pharmaceuticals licenses anti-AIDS compounds from Emory Univ.
    • 216900
    • (1996) Emerging Pharmaceuticals , vol.5 , Issue.6 , pp. 10
  • 12
  • 16
    • 0005310571 scopus 로고    scopus 로고
    • Triangle Pharmaceuticals reports of DAPD preclinical safety and antiviral activity against drug-resistant HIV strains - Data presented at 39th Annual ICAAC Meeting in San Francisco
    • 341335; September 27
    • (1999) Triangle Pharmaceuticals Inc Press Release
  • 24
    • 0005330043 scopus 로고    scopus 로고
    • Triangle Pharmaceuticals and Abbott Laboratories report drug candidate DAPD decreases viral load in patients infected with resistant virus when added to failing drug regimens - DAPD may provide new salvage therapy
    • 382647; September 18; note
    • (2000) Triangle Pharmaceuticals Inc Press Release


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.